Autopsy report · NCT04994808

Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes or Acute Myeloid Leukemia

“The study was closed due to the end of funding.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 years before it started.
• Ran for about 2 years 11 months before it stopped.
• 23 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Fred Hutchinson Cancer Center

Sponsor type

University, hospital or other

Conditions

Acute Myeloid Leukemia; Myelodysplastic Syndrome

Interventions

Clofarabine; Fludarabine; Hematopoietic Cell Transplantation; Total-Body Irradiation; Treosulfan; Echocardiography Test

Participants

23

Sites

1

Countries

United States

Trials that died the same way

• Changes in Bone Turnover With Increased Incretin Hormone Exposure
  “Study closed by sponsor. Funding ended.” (91% match in meaning)
• Abuse Potential of Buprenorphine/Naloxone
  “Funding ended for the study” (88% match in meaning)
• Managing Chronic Tendon Pain by Metformin
  “The study funding has ended.” (84% match in meaning)
• A Phase 1, Open-Label Study of Intravenous Sildenafil in Patients With Cirrhosis
  “The study is closed due to lack of funding to support the study.” (84% match in meaning)
• Mechanisms of Interferon Gamma-primed Mesenchymal Stromal Cells (MSCs) for Moderate-to-severe Persistent Asthma
  “The study terminated due to funding ending.” (83% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.